Peter Attia· MD
basically in in let's go with that number 80% of patients you know we can identify a mutated uh antigen that will only be in the cancer cells and introduce into the their immune cells a surface recognizer if you will
Loading…
The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
basically in in let's go with that number 80% of patients you know we can identify a mutated uh antigen that will only be in the cancer cells and introduce into the their immune cells a surface recognizer if you will
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.